
Semaglutide’s Impact on Gut Microbiota in American Males: A 24-Week Study
Reading Time: 2 minutes Introduction Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has garnered significant attention for its efficacy in managing type 2 diabetes and obesity. Recent research has begun to explore its effects beyond metabolic control, particularly its influence on gut microbiota. This article delves into the changes observed in the gut microbiota of American males undergoing semaglutide treatment, offering insights into potential broader health implications. Background on Semaglutide Semaglutide is primarily used for its ability to enhance glycemic control and promote weight loss. By mimicking the GLP-1 hormone, it slows gastric emptying, increases insulin secretion, and reduces appetite. While its metabolic benefits...